TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization

被引:0
作者
Stéphanie Jouannet
Julien Saint-Pol
Laurent Fernandez
Viet Nguyen
Stéphanie Charrin
Claude Boucheix
Christel Brou
Pierre-Emmanuel Milhiet
Eric Rubinstein
机构
[1] Inserm,
[2] Université Paris-Sud,undefined
[3] Institut André Lwoff,undefined
[4] Inserm,undefined
[5] Université de Montpellier,undefined
[6] CNRS,undefined
[7] UMR5048,undefined
[8] Centre de Biochimie Structurale,undefined
[9] Institut Pasteur,undefined
[10] Laboratoire “Signalisation et Pathogenèse”,undefined
来源
Cellular and Molecular Life Sciences | 2016年 / 73卷
关键词
Membrane compartmentalization; Notch; ADAM10; Tetraspanin; Ectodomain shedding; Microdomain;
D O I
暂无
中图分类号
学科分类号
摘要
The metalloprotease ADAM10 mediates the shedding of the ectodomain of various cell membrane proteins, including APP, the precursor of the amyloid peptide Aβ, and Notch receptors following ligand binding. ADAM10 associates with the members of an evolutionary conserved subgroup of tetraspanins, referred to as TspanC8, which regulate its exit from the endoplasmic reticulum. Here we show that 4 of these TspanC8 (Tspan5, Tspan14, Tspan15 and Tspan33) which positively regulate ADAM10 surface expression levels differentially impact ADAM10-dependent Notch activation and the cleavage of several ADAM10 substrates, including APP, N-cadherin and CD44. Sucrose gradient fractionation, single molecule tracking and quantitative mass-spectrometry analysis of the repertoire of molecules co-immunoprecipitated with Tspan5, Tspan15 and ADAM10 show that these two tetraspanins differentially regulate ADAM10 membrane compartmentalization. These data represent a unique example where several tetraspanins differentially regulate the function of a common partner protein through a distinct membrane compartmentalization.
引用
收藏
页码:1895 / 1915
页数:20
相关论文
共 359 条
[1]  
Blobel CP(2005)ADAMs: key components in EGFR signalling and development Nat Rev Mol Cell Biol 6 32-43
[2]  
Saftig P(2011)The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol 90 527-535
[3]  
Reiss K(2011)Alpha-secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential J Neurochem 116 10-21
[4]  
Lichtenthaler SF(2009)The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 216-233
[5]  
Kopan R(2009)Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling Mol Cell Biol 29 5679-5695
[6]  
Ilagan MX(2009)Metalloprotease ADAM10 is required for Notch1 site 2 cleavage J Biol Chem 284 31018-31027
[7]  
Bozkulak EC(2014)Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins Mol Cell Biol 34 2822-2832
[8]  
Weinmaster G(2002)The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts Hum Mol Genet 11 2615-2624
[9]  
van Tetering G(2008)ADAM10 is essential for proteolytic activation of Notch during thymocyte development Int Immunol 20 1181-1187
[10]  
van Diest P(2010)The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex J Neurosci 30 4833-4844